Caitlin S. Williamson
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Caitlin S. Williamson has a total of 38 co-authors. Here are the top co-authors by number of shared publications:
- William C. Spanos
Sanford Research, Cancer Biology and Immunotherapies Group
2 shared publications - Abigail Z. Bennett
Michigan State University 1 Department of Microbiology, Genetics, and Immunology East Lansing, Michigan
1 shared publication - Andrew J. Olive
Department of Microbiology, Genetics, and Immunology, College of Osteopathic Medicine, Michigan State University , East Lansing, MI
1 shared publication - Anthony Restaino
Sanford Research, Cancer Biology and Immunotherapies Group
1 shared publication Attila Kovács
Cancer Biology and Immunotherapies Group, Sanford Research, Sioux Falls, SD, USA
1 shared publicationAustin Walz
Cancer Biology and Immunotherapies Group, Sanford Research, Sioux Falls, SD, USA
1 shared publication
Latest Publications
- Open Access
- 2 November 2026
- Published by American Association for Cancer Research (AACR) in Cancer Immunology Research
- p. OF1-OF16
ULK1-Dependent Autophagy Initiation Promotes MHC-I Degradation and Immune Evasion in HPV-Positive Head and Neck Cancer
Antigen presentation by MHC class I (MHC-I) is critical for tumor cell killing by CD8+ T cells. In human papillomavirus–positive head and neck cancer (HPV+ HNC), in which MHC-I downregulation is frequent despite favorable immune cell infiltration, lower MHC-I levels are associated with poor responses to immune checkpoint inhibitor therapy. However, the mechanism of MHC-I degradation remains elusive. Genome-wide CRISPR screens in HPV+ HNC identified components of the ULK1 and PIK3C3 autophagy initiation complexes among top negative regulators of cell surface MHC-I. In contrast, inhibiting postinitiation stages of autophagy did not restore cell surface MHC-I, highlighting a critical role for autophagy initiation in regulation of MHC-I. Mechanistically, we showed that MHC-I is recruited from the endoplasmic reticulum to autophagosomes by the cargo receptor NDP52. Finally, inhibition of autophagy initiation suppressed HPV+ HNC tumor growth in vivo and enhanced the CD8+ T cell–mediated antitumor response. Our findings suggest that autophagic degradation of MARCHF8-ubiquitinated MHC-I is a key immune evasion mechanism in HPV+ HNC.
- 2 November 2026
- Published by American Association for Cancer Research (AACR) in Cancer Immunology Research
- p. OF1-OF16
Open AccessULK1-Dependent Autophagy Initiation Promotes MHC-I Degradation and Immune Evasion in HPV-Positive Head and Neck Cancer
Antigen presentation by MHC class I (MHC-I) is critical for tumor cell killing by CD8+ T cells. In human papillomavirus–positive head and neck cancer (HPV+ HNC), in which MHC-I downregulation is frequent despite favorable immune cell infiltration, lower MHC-I levels are associated with poor responses to immune checkpoint inhibitor therapy. However, the mechanism of MHC-I degradation remains elusive. Genome-wide CRISPR screens in HPV+ HNC identified components of the ULK1 and PIK3C3 autophagy initiation complexes among top negative regulators of cell surface MHC-I. In contrast, inhibiting postinitiation stages of autophagy did not restore cell surface MHC-I, highlighting a critical role for autophagy initiation in regulation of MHC-I. Mechanistically, we showed that MHC-I is recruited from the endoplasmic reticulum to autophagosomes by the cargo receptor NDP52. Finally, inhibition of autophagy initiation suppressed HPV+ HNC tumor growth in vivo and enhanced the CD8+ T cell–mediated antitumor response. Our findings suggest that autophagic degradation of MARCHF8-ubiquitinated MHC-I is a key immune evasion mechanism in HPV+ HNC.
- Open Access
- 12 May 2023
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 9 (19) , eade4443
Functional neuronal circuits promote disease progression in cancer
The molecular and functional contributions of intratumoral nerves to disease remain largely unknown. We localized synaptic markers within tumors suggesting that these nerves form functional connections. Consistent with this, electrophysiological analysis shows that malignancies harbor significantly higher electrical activity than benign disease or normal tissues. We also demonstrate pharmacologic silencing of tumoral electrical activity. Tumors implanted in transgenic animals lacking nociceptor neurons show reduced electrical activity. These data suggest that intratumoral nerves remain functional at the tumor bed. Immunohistochemical staining demonstrates the presence of the neuropeptide, Substance P (SP), within the tumor space. We show that tumor cells express the SP receptor, NK1R, and that ligand/receptor engagement promotes cellular proliferation and migration. Our findings identify a mechanism whereby intratumoral nerves promote cancer progression.
- 12 May 2023
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 9 (19) , eade4443
Open AccessFunctional neuronal circuits promote disease progression in cancer
The molecular and functional contributions of intratumoral nerves to disease remain largely unknown. We localized synaptic markers within tumors suggesting that these nerves form functional connections. Consistent with this, electrophysiological analysis shows that malignancies harbor significantly higher electrical activity than benign disease or normal tissues. We also demonstrate pharmacologic silencing of tumoral electrical activity. Tumors implanted in transgenic animals lacking nociceptor neurons show reduced electrical activity. These data suggest that intratumoral nerves remain functional at the tumor bed. Immunohistochemical staining demonstrates the presence of the neuropeptide, Substance P (SP), within the tumor space. We show that tumor cells express the SP receptor, NK1R, and that ligand/receptor engagement promotes cellular proliferation and migration. Our findings identify a mechanism whereby intratumoral nerves promote cancer progression.